Most have been devised for use with children but are often applied to adult patients. There has been only a limited evaluation of reproducibility and reliability of such scores and of their relation to other indicators of the extent of lung disease. There is therefore a need to question their value in clinical practice and research, and in the context of newer imaging techniques. In this issue of Thorax two papers are published that compare the main scoring methods and describe a new scoring system.9 1'
The earliest radiographic changes indicating lung disease in cystic fibrosis are overinflation or atelectasis, probably related to mucus plugging. With progression from a bronchiolitis to bronchitis, bronchial wall thickening occurs giving radiographic circular lesions or tramlines depending on the orientation of the bronchi to the x ray beam. Progressive bronchiectasis is associated with the appearance of cysts and rounded opacities, depending on their content of mucopus, which may coalesce into large lesions. Fibrotic changes may cause a generalised increase in background shadowing on the radiograph. Previous scoring systems have rated the severity or extent of such changes and have been used both to monitor management and to define severity of lung disease for research purposes. With the widespread changes present in the lungs of adult patients scoring systems may be less sensitive, although many centres still use them as part of an annual assessment of their patients.
Conway et al3 (pp 860-2) report a new system based on a straightforward assessment of a posteroanterior chest radiograph by a single observer. The merits of this method are simplicity, rapidity, and results comparable with other currently used systems. In a separate comparison, also involving the Brasfield method, three methods were shown by Sawyer et al'o (pp 863-6) to vary in repeatability and to have only a modest relation to spirometry, indicating that much of the variability in scores was not related to spirometric indicators of lung disease.'0
The inherent weakness of radiographic scoring systems is the lack of relation of plain radiographic changes to the pathological process occurring in the lungs. High resolution computed axial tomography can clarify and extend changes demonstrated on the plain radiograph" 12 by showing both the distribution and severity of bronchiectasis. Changes demonstrated by computed tomographic scanning relate more to the understood pathology (for example, mucus plugging, consolidation, bronchiectasis and bronchial wall thickening) than to linear shadows, cysts, or nodularity which are noted in chest radiograph scores. Computed tomographic scanning will often demonstrate early involvement of the lungs at a time when the chest radiograph may appear to be normal. However, computed tomographic scanning involves considerably greater exposure to radiation than a series of chest radiographs over 10-20 years. It is interesting that scoring systems have also been developed for the computed tomographic scan, based on specific changes, but are not currently in routine usage. '2 It is likely that scoring systems for the chest radiograph will continue to be used by physicians and, with some refinements, may be of value in the assessment of the clinical status of both paediatric and adult patients with cystic fibrosis. The application to research of such scores may be less useful and computed tomographic assessment may have a role here. 
